Key Levels For Neurotrope Ahead Of Alzheimer's Data Release

Neurotrope will be releasing pivotal data of their Alzheimer's drug tomorrow. Expect a volatile day of trading. A fail would result in the stock testing potential support levels including: $14.50, $11.00, and $8.00.

Indecisive data or a positive spin from the company on not so stellar data would probably result in the stock trading range bound between $14.50 and $20.70.

Positive data could see a sharp move higher to March 2017 highs of $29.00 .

Consensus from the bio-Twitter community is bearish:


Popular Posts